Wishing you all the joys of the season! 
Asia Pacific Bioreactors Market Forecast to 2030
Asia Pacific Bioreactors Market Forecast to 2030 – Regional Analysis – by Scale (Lab-Scale Production, Pilot-Scale Production, and Full-Scale Production), Application (Microbial Application, Cell Culture Application, and Others), Technology (Fed-Batch Bioreactors and Perfusion Bioreactors), and End User (Biopharma Manufacturers, Research and Development Organizations, and Contract Manufacturing Organization)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Technological Advancements in Bioreactors Boost Asia Pacific Bioreactors Market
Advancement in the field of bioreactors has opened many opportunities for the market players. Leading players have come up with innovative products in the last few years. The improvement in the bioreactors offers a faster and easier production of biopharmaceuticals at reduced production costs. Also, the investments from public and private investors are rising for the bioreactors. The rise in the venture is enabling technological developments and standard biological parts. In February 2021, WuXi Biologics’ MFG5 Drug Substance (DS) manufacturing facility in China launched a GMP operation with a capacity of 36,000L and deployed nine 4,000L single-use bioreactors. As a major milestone in the company’s global capacity planning, the GMP implementation of MFG5 increases WuXi Biologics’ current capacity to 90,000L, significantly expanding its ability to support global partners.
The new bioreactors are developed for the growth of adherent cells on microcarriers that enable rapid, scalable cell culture processes in the development of vaccines. The launch of such new bioreactors enhanced the portfolio of the company in the bioreactors market.
Advancement in bioreactors has added various solutions for most industries, such as pharmaceutical, petrochemical, food, and agriculture. Therefore, technological advancements are expected to boost innovations in the bioreactors market in the coming years.
Asia Pacific Bioreactors Market Overview
In China, bioreactors have experienced tremendous growth owing to an increasing number of bioreactors projects and partnerships in the country. Developments such as partnerships and increasing focus on research and development activities by pharmaceutical and biotechnology companies have accelerated the growth of the market in China. For instance, in January 2022, Shanghai ZhenGe Biotech Co., Ltd., a contract development and manufacturing organization (CDMO) service provider, completed a successful round C financing, raising a total of US$ 100 million. The funding round was led by Goldman Sachs Asset Management and Sofina, with additional investments from Novo Holdings A/S, Qiming Venture Capital, IDG Capital, LYFE Capital, Junxin Capital, and Cowin Capital. Proceeds from round C strengthened R&D and helped build 15,000L production lines to meet growing demand from existing and new customers with cost-effective and high-quality solutions.
Developments by the companies in China are also boosting the bioreactors market growth. For instance, in October 2023, WuXi Biologics launched a new bioprocessing platform, WuXiUITM, for cost-effective commercial manufacturing and desirable product quality. WuXiUITM intensifies fed-batch solutions, enhancing the productivity and quality of various mammalian cells and product modalities.
The demand for bioreactors is growing further owing to their application in cultured meat production. Over the last several decades, China has made sustained and large R&D investments in biotechnology. One of China’s strategic aims is to use biotechnology to help accomplish national food security goals. Amidst the rise of alternative proteins, China is now turning its attention to the innovative cultivated meat industry.
Asia Pacific Bioreactors Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Bioreactors Market Segmentation
The Asia Pacific bioreactors market is segmented based on scale, application, technology, end user, and country. Based on scale, the Asia Pacific bioreactors market is segmented into lab-scale production, pilot-scale production, and full-scale production. The pilot-scale production segment held the largest market share in 2022.
In terms of application, the Asia Pacific bioreactors market is categorized into microbial application, cell culture application, and others. The cell culture application segment held the largest market share in 2022.
By technology, the Asia Pacific bioreactors market is bifurcated into fed-batch bioreactors and perfusion bioreactors. The fed-batch bioreactors segment held a larger market share in 2022.
Based on end user, the Asia Pacific bioreactors market is categorized into biopharma manufacturers, research and development organizations, and contract manufacturing organization. The research and development organizations segment held the largest market share in 2022.
Based on country, the Asia Pacific bioreactors market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific bioreactors market share in 2022.
Applikon Biotechnology BV, bbi-biotech GmbH, General Electric Co, Merck KGaA, Pall Corp, PBS Biotech Inc, Sartorius AG, Solaris Biotechnology SRL, and Thermo Fisher Scientific Inc are some of the leading players operating in the Asia Pacific bioreactors market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team’ research, the Asia Pacific bioreactors market was valued at US$ 706.74 million in 2022 and is expected to reach US$ 1,488.10 million by 2030, registering a CAGR of 9.8% from 2022 to 2030. Rising demand for personalized medicine and rapid growth of pharmaceutical and biotechnology industry are among the critical factors attributed to the Asia Pacific bioreactors market expansion.
The transformation of the healthcare industry from one-size-fits-all to a targeted approach is expanding the demand for personalized medicine. Precision medicine is being considered as one of the most promising approaches to tackle diseases such as cancer, neurodegenerative diseases, and rare genetic conditions. Innovations in the production of personalized medicines are likely to impact the entire sector, and single-use technologies aimed at smaller-volume production have potential applications in protein bioproduction, particularly in downstream processes. Personalized and differentiated approaches to medicine are leading to a need for a wider range of products, many of them for a relatively small number of patients. A fundamentally different approach to the production and delivery of biological products may be required.
Precision medicine utilizes the genomic information of an individual to offer targeted treatment for a particular indication. The rising prevalence of a number of chronic diseases has increased the demand for biologics, drugs for orphan diseases, and personalized medicines. For instance, in 2019, the FDA approved 12 personalized medications to address the root causes of disease and further integrate precision medicine with clinical care. Also, increasing government efforts are strengthening personalized medicine research activities. For instance, in February 2020, the National Human Genome Research Institute (NHGRI) announced to establish a new precision medicine and genomics program. This program will focus on the innovation of genomics and informatics tools for better diagnosis and treatment of disease. The rising demand for personalized medicine is anticipated to offer significant growth opportunities to the players operating in the bioreactors market during the forecast period.
On the contrary, stringent regulatory framework hurdles the growth of Asia Pacific bioreactors market.
Based on scale, the Asia Pacific bioreactors market is categorized into lab-scale production, pilot-scale production, and full-scale production. The pilot-scale production segment held 48.4% share of Asia Pacific bioreactors market in 2022, amassing US$ 341.86 million. It is projected to garner US$ 710.57 million by 2030 to expand at 9.6% CAGR during 2022–2030.
In terms of application, the Asia Pacific bioreactors market is segmented into microbial application, cell culture application, and others. The cell culture application segment held 48.6% share of Asia Pacific bioreactors market in 2022, amassing US$ 343.28 million. It is projected to garner US$ 713.10 million by 2030 to expand at 9.6% CAGR during 2022–2030.
By technology, the Asia Pacific bioreactors market is bifurcated into fed-batch bioreactors and perfusion bioreactors. The fed-batch bioreactors segment held 62.3% share of Asia Pacific bioreactors market in 2022, amassing US$ 440.28 million. It is projected to garner US$ 887.10 million by 2030 to expand at 9.2% CAGR during 2022–2030.
Based on end user, the Asia Pacific bioreactors market is segmented into biopharma manufacturers, research and development organizations, and contract manufacturing organization. The research and development organizations segment held 60.5% share of Asia Pacific bioreactors market in 2022, amassing US$ 427.83 million. It is projected to garner US$ 946.89 million by 2030 to expand at 10.4% CAGR during 2022–2030.
Based on country, the Asia Pacific bioreactors market has been categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 23.0% share of Asia Pacific bioreactors market in 2022. It was assessed at US$ 162.55 million in 2022 and is likely to hit US$ 392.86 million by 2030, exhibiting a CAGR of 11.7% during 2022–2030.
Key players operating in the Asia Pacific bioreactors market are Applikon Biotechnology BV, bbi-biotech GmbH, General Electric Co, Merck KGaA, Pall Corp, PBS Biotech Inc, Sartorius AG, Solaris Biotechnology SRL, and Thermo Fisher Scientific Inc, among others.
In August 2023, Emerson collaborated with life science group Sartorius to natively integrate Sartorius’s Biostat STR Generation 3 family of bioreactors with Emerson’s DeltaVTM distributed control system (DCS). DeltaV control system natively integrated into Sartorius Biostat STR bioreactors provides a foundation for semi-autonomous operations and up to 80% less integration time. In July 2023, PBS Biotech Inc and Stemcell Technologies Inc have entered into a supply arrangement that will enable researchers to access PBS-MINI Bioreactors. Through this partnership, PBS will support researchers who wish to grow their cultures of human pluripotent stem cells, or hPSCs, which are essential for drug discovery, disease modeling, future cell-based therapeutics, and pharmaceutical applications.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific bioreactors market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific bioreactors market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
TABLE OF CONTENTS
1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Bioreactors Market – Key Industry Dynamics
4.1 Bioreactors Market – Key Industry Dynamics
4.2 Market Drivers
4.2.1 Increasing Adoption of Single-Use Bioreactors
4.2.2 Rapid Growth of Pharmaceutical and Biotechnology Industry
4.3 Market Restraints
4.3.1 Stringent Regulatory Framework
4.4 Market Opportunities
4.4.1 Rising Demand for Personalized Medicine
4.5 Future Trends
4.5.1 Technological Advancements in Bioreactors
4.6 Impact of Drivers and Restraints:
5. Bioreactors Market – Asia Pacific Market Analysis
5.1 Overview
5.2 Bioreactors Market Revenue (US$ Million), 2020 – 2030
6. Asia Pacific Bioreactors Market Analysis – Scale
6.1 Overview
6.2 Bioreactors Market Revenue Share, by Scale 2022 & 2030 (%)
6.3 Lab-Scale Production
6.3.1 Overview
6.3.2 Lab-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Pilot-Scale Production
6.4.1 Overview
6.4.2 Pilot-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)
6.5 Full-Scale Production
6.5.1 Overview
6.5.2 Full-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Bioreactors Market Analysis – Application
7.1 Overview
7.2 Bioreactors Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Microbial Application
7.3.1 Overview
7.3.2 Microbial Application Market, Revenue and Forecast to 2030 (US$ Million)
7.4 Cell Culture Application
7.4.1 Overview
7.4.2 Cell Culture Application Market, Revenue and Forecast to 2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Bioreactors Market Analysis – Technology
8.1 Overview
8.2 Bioreactors Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Fed-Batch Bioreactors
8.3.1 Overview
8.3.2 Fed-Batch Bioreactors Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Perfusion Bioreactors
8.4.1 Overview
8.4.2 Perfusion Bioreactors Market, Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Bioreactors Market Analysis – End User
9.1 Overview
9.2 Bioreactors Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharma Manufacturers
9.3.1 Overview
9.3.2 Biopharma Manufacturers Market, Revenue and Forecast to 2030 (US$ Million)
9.4 Research and Development Organizations
9.4.1 Overview
9.4.2 Research and Development Organizations Market, Revenue and Forecast to 2030 (US$ Million)
9.5 Contract Manufacturing Organization
9.5.1 Overview
9.5.2 Contract Manufacturing Organization Market, Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Bioreactors Market – by Country Analysis
10.1 Asia Pacific: Bioreactors Market
10.1.1 Asia Pacific Bioreactors Market Revenue and Forecasts and Analysis – By Country
10.1.1.1 China
10.1.1.2 Overview
10.1.1.3 China: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 China Bioreactors Market Breakdown by Scale
10.1.1.3.2 China Bioreactors Market Breakdown by Application
10.1.1.3.3 China Bioreactors Market Breakdown by Technology
10.1.1.3.4 China Bioreactors Market Breakdown by End User
10.1.1.4 Japan
10.1.1.5 Overview
10.1.1.6 Japan: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Japan Bioreactors Market Breakdown by Scale
10.1.1.6.2 Japan Bioreactors Market Breakdown by Application
10.1.1.6.3 Japan Bioreactors Market Breakdown by Technology
10.1.1.6.4 Japan Bioreactors Market Breakdown by End User
10.1.1.7 India
10.1.1.8 Overview
10.1.1.9 India: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.9.1 India Bioreactors Market Breakdown by Scale
10.1.1.9.2 India Bioreactors Market Breakdown by Application
10.1.1.9.3 India Bioreactors Market Breakdown by Technology
10.1.1.9.4 India Bioreactors Market Breakdown by End User
10.1.1.10 Australia
10.1.1.11 Overview
10.1.1.12 Australia: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.12.1 Australia Bioreactors Market Breakdown by Scale
10.1.1.12.2 Australia Bioreactors Market Breakdown by Application
10.1.1.12.3 Australia Bioreactors Market Breakdown by Technology
10.1.1.12.4 Australia Bioreactors Market Breakdown by End User
10.1.1.13 South Korea
10.1.1.14 Overview
10.1.1.15 South Korea: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.15.1 South Korea Bioreactors Market Breakdown by Scale
10.1.1.15.2 South Korea Bioreactors Market Breakdown by Application
10.1.1.15.3 South Korea Bioreactors Market Breakdown by Technology
10.1.1.15.4 South Korea Bioreactors Market Breakdown by End User
10.1.1.16 Rest of Asia Pacific
10.1.1.17 Overview
10.1.1.18 Rest of Asia Pacific: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.18.1 Rest of Asia Pacific Bioreactors Market Breakdown by Scale
10.1.1.18.2 Rest of Asia Pacific Bioreactors Market Breakdown by Application
10.1.1.18.3 Rest of Asia Pacific Bioreactors Market Breakdown by Technology
10.1.1.18.4 Rest of Asia Pacific Bioreactors Market Breakdown by End User
11. Bioreactors Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Bioreactors Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 PBS Biotech Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 General Electric Co
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Merck KGaA
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 bbi-biotech GmbH
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 SWOT Analysis
12.5.5 Key Developments
12.6 Sartorius AG
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Pall Corp
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Solaris Biotechnology SRL
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About the Research Team
13.2 Glossary of Terms
LIST OF TABLES
Table 1.            Bioreactors Market Segmentation
Table 2.            China Bioreactors Market Revenue and Forecasts To 2030 (US$ Mn) – By Scale
Table 3.            China Bioreactors Market Revenue and Forecasts To 2030 (US$ Mn) – By Application
Table 4.            China Bioreactors Market Revenue and Forecasts To 2030 (US$ Mn) – By Technology
Table 5.            China Bioreactors Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 6.            Japan Bioreactors Market Revenue and Forecasts To 2030 (US$ Mn) – By Scale
Table 7.            Japan Bioreactors Market Revenue and Forecasts To 2030 (US$ Mn) – By Application
Table 8.            Japan Bioreactors Market Revenue and Forecasts To 2030 (US$ Mn) – By Technology
Table 9.            Japan Bioreactors Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 10.         India Bioreactors Market Revenue and Forecasts To 2030 (US$ Mn) – By Scale
Table 11.         India Bioreactors Market Revenue and Forecasts To 2030 (US$ Mn) – By Application
Table 12.         India Bioreactors Market Revenue and Forecasts To 2030 (US$ Mn) – By Technology
Table 13.         India Bioreactors Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 14.         Australia Bioreactors Market Revenue and Forecasts To 2030 (US$ Mn) – By Scale
Table 15.         Australia Bioreactors Market Revenue and Forecasts To 2030 (US$ Mn) – By Application
Table 16.         Australia Bioreactors Market Revenue and Forecasts To 2030 (US$ Mn) – By Technology
Table 17.         Australia Bioreactors Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 18.         South Korea Bioreactors Market Revenue and Forecasts To 2030 (US$ Mn) – By Scale
Table 19.         South Korea Bioreactors Market Revenue and Forecasts To 2030 (US$ Mn) – By Application
Table 20.         South Korea Bioreactors Market Revenue and Forecasts To 2030 (US$ Mn) – By Technology
Table 21.         South Korea Bioreactors Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 22.         Rest of Asia Pacific Bioreactors Market Revenue and Forecasts To 2030 (US$ Mn) – By Scale
Table 23.         Rest of Asia Pacific Bioreactors Market Revenue and Forecasts To 2030 (US$ Mn) – By Application
Table 24.         Rest of Asia Pacific Bioreactors Market Revenue and Forecasts To 2030 (US$ Mn) – By Technology
Table 25.         Rest of Asia Pacific Bioreactors Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 26.         Recent Inorganic Growth Strategies in the Bioreactors Market
Table 27.         Recent Organic Growth Strategies in the Bioreactors Market
Table 28.         Glossary of Terms, Bioreactors Market
Â
Â
LIST OF FIGURES
Figure 1.          Bioreactors Market Segmentation, By Country
Figure 2.          Impact Analysis of Drivers and Restraints
Figure 3.          Bioreactors Market Revenue (US$ Million), 2020 – 2030
Figure 4.          Bioreactors Market Revenue Share, by Scale 2022 & 2030 (%)
Figure 5.          Lab-Scale Production Market Revenue and Forecasts To 2030 (US$ Million)
Figure 6.          Pilot-Scale Production Market Revenue and Forecasts To 2030 (US$ Million)
Figure 7.          Full-Scale Production Market Revenue and Forecasts To 2030 (US$ Million)
Figure 8.          Bioreactors Market Revenue Share, by Application 2022 & 2030 (%)
Figure 9.          Microbial Application Market Revenue and Forecasts To 2030 (US$ Million)
Figure 10.       Cell Culture Application Market Revenue and Forecasts To 2030 (US$ Million)
Figure 11.       Others Market Revenue and Forecasts To 2030 (US$ Million)
Figure 12.       Bioreactors Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 13.       Fed-Batch Bioreactors Market Revenue and Forecasts To 2030 (US$ Million)
Figure 14.       Perfusion Bioreactors Market Revenue and Forecasts To 2030 (US$ Million)
Figure 15.       Bioreactors Market Revenue Share, by End User 2022 & 2030 (%)
Figure 16.       Biopharma Manufacturers Market Revenue and Forecasts To 2030 (US$ Million)
Figure 17.       Research and Development Organizations Market Revenue and Forecasts To 2030 (US$ Million)
Figure 18.       Contract Manufacturing Organization Market Revenue and Forecasts To 2030 (US$ Million)
Figure 19.       Asia Pacific: Bioreactors Market, by Key Country – Revenue (2022) (US$ Million)
Figure 20.       Asia Pacific Bioreactors Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 21.       China Bioreactors Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 22.       Japan Bioreactors Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 23.       India Bioreactors Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 24.       Australia Bioreactors Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 25.       South Korea Bioreactors Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 26.       Rest of Asia Pacific Bioreactors Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 27.       Growth Strategies in the Bioreactors Market
The List of Companies – Asia Pacific Bioreactors Market
o Applikon Biotechnology BV
o bbi-biotech GmbH
o General Electric Co
o Merck KGaAÂ
o Pall Corp
o PBS Biotech Inc
o Sartorius AG
o Solaris Biotechnology SRL
o Thermo Fisher Scientific Inc
You must be logged in to post a review.
Reviews
There are no reviews yet.